The Effect of Cold Application in Patients With Rheumatoid Arthritis
1 other identifier
interventional
90
1 country
1
Brief Summary
The aim of this thesis is to examine the effects of cold application on pain, disease activity, and quality of life in patients with Rheumatoid Arthritis. Currently, non-pharmacological interventions, such as cold therapy, are utilized less frequently than pharmacological treatments for the management of pain in inflamed joints. Cold application is anticipated to alleviate pain and consequently enhance patients' quality of life. This study seeks to improve quality of life by reducing pain in patients with Rheumatoid Arthritis. Given its simplicity, ease of application, and low cost, this intervention may be recommended as a pain management strategy both for patients and for nurses working in clinical settings. Furthermore, the study aims to contribute to the existing literature on the subject.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2024
CompletedFirst Submitted
Initial submission to the registry
January 14, 2026
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2026
ExpectedJanuary 23, 2026
January 1, 2026
1.1 years
January 14, 2026
January 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Rheumatoi Arthritis Disease Activity Index-5
The Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5) is a patient-reported outcome measure designed to assess disease activity in individuals with rheumatoid arthritis
3 weeks
Secondary Outcomes (1)
The Short Form Health Survery- SF-36
3 weeks
Study Arms (2)
Cold Application Group
EXPERIMENTALPatients will be instructed to apply cold therapy three times daily for 15 minutes each session over a period of three weeks. Patients will report their daily cold application to the researcher via text message. For those unable to provide updates via text, the researcher will follow up daily by phone to monitor adherence to the intervention.
Control Group
NO INTERVENTIONThis patient group will undergo follow-up assessment after a three-week period during which no intervention will be administered.
Interventions
Patients will be instructed to apply cold therapy three times daily for 15 minutes each session over a period of three weeks. Patients will report their daily cold application to the researcher via text message. For those unable to provide updates via text, the researcher will follow up daily by phone to monitor adherence to the intervention.
Eligibility Criteria
You may qualify if:
- Having been diagnosed with rheumatoid arthritis at least 6 months ago,
- No problems with speaking, communicating, hearing, or understanding,
- Able to understand and speak Turkish,
- Experiencing pain.
You may not qualify if:
- Patients who are in remission
- Individuals of foreign nationality
- People with psychiatric or mental illnesses
- Patients who do not consent to participate in the study or who withdraw at any stage of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of health sciences Saglik Bilimleri University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 14, 2026
First Posted
January 22, 2026
Study Start
December 10, 2024
Primary Completion
January 30, 2026
Study Completion (Estimated)
May 29, 2026
Last Updated
January 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share